ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

AACR Completes List Of Symposia Chairpersons

April 22, 1988

UICC Announces Grant Programs to Continue

April 15, 1977

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008

NCAB Committee Close To Definition Of QRA

February 11, 1983